 |
 |

|

|
 |






|
 |
 |

PROFILE
 The 21st century has been termed the century of biology. It is now becoming
apparent that discoveries in biology and in the life sciences will heavily
influence our lives in the coming decades. The impact of future developments in
these fields will be tremendous, leading to advances in the understanding of
basic disease mechanisms. This will trigger a dramatic increase in the demand
for improved treatment modalities and hence also an increase in treatment
expectations. These trends are strongly fuelled by an ageing population in
industrialised countries and an overall growing population world-wide. In
addition, clean solutions to environmental pollution and energy
generation problems will ultimately and significantly rely on biological
mechanisms. This opens up a completely new and yet mostly unexplored field of
commercial opportunities.
EMBL Ventures specialises its investment activities on biology and life-science
related products and technologies, to tap into these highly attractive markets
and allow its investors to participate in their future growth. With
several years experience in early stage investing, EMBL Ventures provides
long-term equity financing to entrepreneurs to build and strengthen their
companies and to realize their company vision. EMBL Ventures typically serves as
the lead investor for initial financing and also participates in follow-on
financing.
|
|
 |